The drug, an inhaled powder, completed phase III testing in August of 2013. If approved, it will be the first ultra rapid-acting mealtime insulin therapy available in the United States.
Read more
DiabetesHealth – Inhaled Insulin to Treat Diabetes Earns FDA Committee Recommendation
Posted in Glucose & Insulin